Erratum to “Arteriopathy after transarterial chemo-lipiodolization for hepatocellular carcinoma” [Diagn. Interv. Imaging 98 (12) (2017) 827–35](S2211568417302784)(10.1016/j.diii.2017.10.010)

Y. Matsui, A. Figi, M. Horikawa, Y. Jahangiri Noudeh, Y. Tomozawa, K. Hashimoto, John Kaufman, Khashayar Farsad

Research output: Contribution to journalComment/debate

Abstract

In their article, the authors wish to correct the presentation of Table 1. In addition, the authors wish to complete their disclosure statement. Disclosure of interests: Activities related to the present article: K.F. received a grant from Guerbet for this study. Activities not related to the present article: Y.M. a grant from Japan Radiological Society supported by Bayer Yakuhin; a consultancy fee from Stryker Japan; a lecture's fee from Terumo Corporation. J.A.K. grants from NIH, WL Gore, and BTG; personal fees from VIVA Physicians, Delcath, MarrowStim and COOK Medical; book royalties and journal editor stipend from Elsevier; section editor stipend from ARRS/AJR; stock ownership in Hatch Medical, Vu Medi, Endoshape, and Veniti; stock options in Javelin Medical, AV Medical, and BIO2 Medical. A.F., M.H., Y.J., Y.T., and K.H. declare that they have no competing interest.

Original languageEnglish (US)
Pages (from-to)183-184
Number of pages2
JournalDiagnostic and interventional imaging
Volume99
Issue number3
DOIs
StatePublished - Mar 1 2018

    Fingerprint

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology
  • Radiology Nuclear Medicine and imaging

Cite this